PSI reaches into Austria; Almac inks a $365M Roche deal;

> Swiss CRO PSI has opened a new outpost in Vienna, part of a sweeping effort to expand across Europe. More

> Almac's drug discovery operation has inked a deal with Roche's ($RHHBY) Genentech, out-licensing a cancer program for $14.5 million up front and as much as $349 million in milestones. News